Avrobio Inc | AVRO - Assets

Avrobio Inc reported $103.95M in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Akebia Therapeutics AKBA:US USD 351.83M 84.06M
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Gilead Sciences GILD:US USD 63.17B 614M
Intercept Pharmaceuticals ICPT:US USD 553.71M 5.69M
IONIS PHARMACEUT IONS:US USD 2.53B 111.9M
Karyopharm Therapeutics KPTI:US USD 358.17M 126.94M
Macrogenics MGNX:US USD 280.47M 85.12M
Roche Holding ROG:VX 88.15B 1.42B
Sangamo Biosciences SGMO:US USD 562.51M 31.4M
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
Takeda 4502:JP JPY 13.5T 1.08T